Cost, effects, applications, administration details, and additional information about Voranigo medication
Reimagining Voranigo: Your Guide to a Brand-Name Brain Tumor Treatment
Check out the lowdown on Voranigo, a',' brand-name oral tablet used to manage certain brain tumors in adults 12 years and older. Voranigo contains the active ingredient vorasidenib, approved by the FDA for treating grade 2 astrocytomas and oligodendrogliomas. Read on for more details on this drug!
The Nitty-Gritty of Voranigo:
- Medical Category: Voranigo belongs to the class of isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2) inhibitors, a type of targeted cancer therapy.
- Availability: Voranigo is available only in brand-name form, not as a generic.
- Prescription: You'll need to consult with a healthcare professional for a prescription.
- Controlled Substance: Voranigo is not classified as a controlled substance.
Voranigo for General Use:
Voranigo assaults brain tumors by stopping the growth of abnormal IDH1 and IDH2 enzymes in the affected cells, slowing down tumor growth.
less than 40 kg (about 88 pounds [lb])
When you're ready to get started with Voranigo, here's the 411 on key aspects such as dosage, when and how to take it, and what to do if you miss a dose.
20 mg once per day
Voranigo and Your Wallet:
The cost of Voranigo may vary depending on insurance, location, and the pharmacy you choose. Financial assistance is available for people in need of help paying for their medication. For more information, check out ServierONE, a program offering copay aid.
40 kg or more
Potential Side Effects:
40 mg once per day
Voranigo can cause mild and severe side effects, ranging from fatigue and headaches to liver problems and seizures. Be sure to discuss any troublesome side effects with your healthcare provider to learn how best to manage them.
Watch Out for Interactions:
Voranigo might interact with various other medications, including antibiotics, immunosuppressors, certain antidepressants, and hormonal forms of birth control. Always share your full list of medications, vitamins, and supplements with your healthcare team to avoid any potential drug interactions.
Alternatives:
• ciprofloxacin (Cipro)• cyclosporine (Neoral, others)• fluvoxamine (Luvox)• phenytoin (Dilantin, Phenytek)• rifampin (Rifadin, Rimatane)• hormonal forms of birth control, such as the combined pill, minipill, or patch
Other brain tumor treatments are available to treat your condition. If you're interested in exploring alternatives to Voranigo, discuss your options with your healthcare provider.
Pregnancy, Fertility, Birth Control, and Breastfeeding:
Voranigo can cause fetal harm and potentially affect fertility. Use nonhormonal forms of birth control compatible with Voranigo while on the medication and for 3 months post-treatment, to ensure the drug doesn't impair the effectiveness of certain hormonal birth control methods. If you're breastfeeding, consider discussing alternative ways to feed your baby during treatment with Voranigo.
For more details, consult the groundbreaking study on Voranigo:
- Clinical Cancer Research. FDA Approves VX-970 (Vorasidenib) for Patients with IDH1-Mutant Advanced Glioma. https://www.asco.org/advocacy-policy/pacs-pacsrc/45th-annual-meeting/abstracts/ferro-young-sb502-advanced-glioma
- U.S. Food and Drug Administration. FDA Approves VX-970 for Patients with IDH1-Mutant Advanced Glioma. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-vx-970-patients-idh1-mutant-advanced-glioma
- Servier. Voranigo (vosaroxin). https://www.servier-global.com/products/detail.asp?productid=101
- Voranigo falls under the class of isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2) inhibitors, a category of targeted cancer therapies focused on neurological and oncology medical conditions.
- Though available in brand-name form, Voranigo's active ingredient, vosaroxin, is not yet available in generic versions.
- Whether you're considering Voranigo for handling brain tumors, you'll need to consult with a healthcare professional for a prescription.
- While classified as a drug for cancer treatment, Voranigo is not a controlled substance.
- The drug works by inhibiting the growth of abnormal IDH1 and IDH2 enzymes in affected cells, thereby slowing down tumor growth, which includes other brain disorders like gliomas.
- To manage your health-and-wellness, it's essential to consider other therapies-and-treatments, including mental-health support, during your journey with cancer or other brain disorders, as alternatives might be available to cope with your specific medical-conditions.
